AstraZeneca Expands AI Collaboration with SOPHiA GENETICS for Breast Cancer Research

AstraZeneca and SOPHiA GENETICS have expanded their partnership in a new multi-year collaboration focused on advancing breast cancer research and treatment using artificial intelligence (AI) technologies124.

The collaboration will leverage SOPHiA GENETICS’s multimodal AI Factories, which analyze diverse healthcare datasets (including genomics, imaging, and clinical data) to generate evidence on the efficacy, value, and real-world impact of specific breast cancer therapies1234.

A core goal is the potential development of bespoke AI-powered predictive models aimed at optimizing treatment outcomes for breast cancer patients123.

The initiative includes a focus on generating and analyzing real-world evidence in both Europe and North America to uncover treatment efficacy drivers, address knowledge gaps, and enhance clinical decision-making by providing actionable insights124.

SOPHiA GENETICS’s AI is designed to provide powerful predictive insights for assessing patient prognosis and treatment response, utilizing one of the most diverse multimodal healthcare datasets available12.

Sources:

1. https://www.biospace.com/press-releases/sophia-genetics-expands-collaboration-with-astrazeneca-using-ai-to-improve-breast-cancer-patient-outcomes

2. https://www.barchart.com/story/news/33880597/sophia-genetics-expands-collaboration-with-astrazeneca-using-ai-to-improve-breast-cancer-patient-outcomes

3. https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-expands-collaboration-with-astra-zeneca-using-ai-huwab81e6lye.html

4. https://www.prnewswire.com/news-releases/sophia-genetics-expands-collaboration-with-astrazeneca-using-ai-to-improve-breast-cancer-patient-outcomes-302521027.html